Skip to main content

Journal article Published 2023

A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis

Authors

D.E. Peters, L.D. Norris, L. Tenora, I. Snajdr, A. Ponti, X. Zhu, S. Sakamoto, V. Veervalli, M. Pradhan, J. Alt, A.G. Thomas, P. Majer, R. Rais, Ch. McDonald, B.S. Slusher

Science Translational Medicine 15(708), eabn7491 (2023)

Cite this publication

PETERS, D., L. NORRIS, L. TENORA, I. SNAJDR, A. PONTI, X. ZHU, S. SAKAMOTO, V. VEERVALLI, M. PRADHAN, J. ALT, A. THOMAS, P. MAJER, R. RAIS, C. MCDONALD, B. SLUSHER: A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis. Science Translational Medicine. 2023, 15(708), eabn7491, ISSN: 1946-6234, PMID: 37556558.

Details

ISSN
1946-6234